News

Initial customers have already adopted the system to characterize CTCs for biomarkers such as gene expression, mutations, and chromosomal aberrations. Designed for high sensitivity enrichment of rare cells

Composition of a series of prodrugs activated by HK2 enzyme to deliver a thapsigargin derivative selectively targeting prostate cancers is protected by the patent. GenSpera CEO Craig Dionne

Scheduled to commence operations early in 2016, the new facility will be the first to use mammalian cell culture technology in the production of biopharmaceuticals in China. Set

As a fully-serviced outsourcing partner, NextPharma will offer primary and secondary packaging solutions within the European territory. MPE vice president Toshiaki Mikuni said, "We needed a partner with

The total consideration for acquiring the rights will be funded from existing cash and bank facilities, including a £3.5m drawdown from the group’s £30m acquisition facilities. About $0.3m

The findings showed that small inhaled doses yielding high peak, short duration lung pirfenidone concentrations provide statistically greater anti-fibrotic efficacy than higher oral doses resulting in low peak

The product, which was produced in Korea, was recalled three years ago, when the new management discovered that the supplement included, and did not list, Sildenafil on the

The acquisition follows the integration of RxAssist into the RxVantage system in May this year. RxVantage’s online scheduling platform can now be accessed by RepAccess’ medical office users

Commenting on the introduction, BioSyent president and CEO René Goehrum said that the launch of FeraMAX Powder further strengthens the company’s position as a iron supplement solutions provider